Cigarette smoking has been extensively studied in the context of diabetes risk, but what's known about the impact of smokeless tobacco on glycemic control and metabolic health?
Poor muscle quality is commonly underdiagnosed in people with obesity. Explore the definitions, assessment methods, associated health outcomes, and potential interventions.
The increasing availability and intake of UPFs is occurring alongside the rising incidence of obesity and type 2 diabetes. Examine the evidence linking UPFs with excess type 2 diabetes risk.
People with type 2 diabetes beginning GLP-1 receptor agonist therapy have a short-term increased risk of thyroid cancer compared with those who initiate alternative diabetes medications.
ICI-related diabetes developed after 18 months of nivolumab treatment for malignant melanoma. Diffusion-weighted imaging may provide valuable insights into pancreatic involvement at an early stage of the disease.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
ICI-related diabetes developed after 18 months of nivolumab treatment for malignant melanoma. Diffusion-weighted imaging may provide valuable insights into pancreatic involvement at an early stage of the disease.
Testing ketone levels and brain MRI is essential for unconscious patients on SGLT2 inhibitors. Patients on these drugs are at increased risk of euglycemic diabetic ketoacidosis, which may cause metabolic encephalopathy.
A young woman diagnosed with minimal change nephrotic syndrome in childhood developed latent autoimmune diabetes in adults and Graves disease. HLA testing was performed to investigate her genetic background.
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Diabetes mellitus (DM) is a chronic metabolic disorder that affects millions of people worldwide and is characterized by dysglycemia and insulin resistance [ 1 , 2 ]. It can be classified into two types: type 1 and Type 2 diabetes, each having …
Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by the destruction of insulin-producing beta cells in the pancreas, leading to insulin deficiency and chronic hyperglycemia. The main current therapeutic strategies for …
In this review, we discuss how partnership and marriage influence cardiometabolic risk factors and risk of type 2 diabetes, and how couple-based approaches to type 2 diabetes prevention might complement individual-focused prevention efforts. There …
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Metformin provides a modest effect for weight loss and prevents macroangiopathy such as cardiovascular outcomes in patients with type 2 diabetes with obesity and insulin resistance [ 1 , 2 ]. Based on therapeutic and patient-side clinical factors …
Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by the destruction of insulin-producing beta cells in the pancreas, leading to insulin deficiency and chronic hyperglycemia. The main current therapeutic strategies for …
The etiology of Graves’ disease (GD) with Graves’ ophthalmopathy (GO) is multifaceted and complex. GO primarily arises from inflammatory infiltration, fat accumulation, and muscle tissue expansion [ 1 ]. Recent studies have highlighted the …
Diabetic nephropathy (DN) is one of the common serious microvascular complications of diabetes mellitus (DM). Diabetic nephropathy occurs in about 20 to 40% of all diabetics who eventually develop end-stage kidney disease [ 1 ]. So, the diagnosis …
Cigarette smoking has been extensively studied in the context of diabetes risk, but what's known about the impact of smokeless tobacco on glycemic control and metabolic health?
Poor muscle quality is commonly underdiagnosed in people with obesity. Explore the definitions, assessment methods, associated health outcomes, and potential interventions.
Diabetic foot infections are a significant clinical challenge. A comprehensive approach, including novel antimicrobial therapies and drug delivery systems, is needed to improve outcomes and combat antimicrobial resistance.
Diabetes and NET can adversely affect each other’s prognosis, but what impact do NET therapies have on diabetes and vice versa? And how should radiological and functional procedures be managed in patients with NET and diabetes?
